Business Context and Reporting Period
Company: American Shared Hospital Services (ASHS)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2008
Business Overview: ASHS provides Gamma Knife radiosurgery units and radiation therapy equipment to medical centers. As of June 30, 2008, the Company operated 18 Gamma Knife units across the United States. The Company also holds a strategic investment in Still River Systems, Inc., a developer of proton beam radiation therapy systems.
Key Financial Metrics
| Metric (Six Months Ended June 30) | 2008 | 2007 |
|---|---|---|
| Revenue | $9,827,000 | $9,659,000 |
| Gross Margin | $4,412,000 (44.9%) | $4,676,000 (48.4%) |
| Operating Income | $981,000 | $1,369,000 |
| Net Income | $369,000 | $505,000 |
| Diluted EPS | $0.07 | $0.10 |
| Cash from Operating Activities | $3,840,000 | $7,466,000 |
| Cash and Equivalents (End of Period) | $8,587,000 | $5,012,000 |
| Total Debt (Current + Long-Term) | $31,601,000 | $N/A (Derived from Balance Sheet) |
| Working Capital | $1,834,000 | $N/A |
Note: Total Debt calculated as Current portion of long-term debt ($7,922,000) + Advances on line of credit ($4,000,000) + Current portion of capital leases ($1,095,000) + Long-term debt ($19,679,000) + Long-term capital leases ($5,101,000).
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 1.7% year-over-year for the six-month period. This growth was driven by a 12% increase in revenue at existing Gamma Knife sites and new revenue from a radiation therapy contract operational since September 2007.
- Procedure Volume Decline: Despite revenue growth, the number of Gamma Knife procedures decreased by 250 (20.3%) to 978 for the six-month period. This decline was attributed to the termination of three contracts and equipment downtime for upgrades.
- Profitability Compression: Net income decreased 27% to $369,000. Gross margin percentage declined from 48.4% to 44.9% due to increased depreciation and amortization ($330,000 increase) related to new Perfexion units and equipment upgrades.
- Interest Expense: Interest expense rose 27.5% to $1,195,000, primarily due to term financing for equipment upgrades and cobalt reloads, partially offset by lower line-of-credit borrowing.
- Asset Sale: The Company recorded a $56,000 gain and received $1,473,000 in cash proceeds from the sale of a Gamma Knife unit following an early termination by a customer.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes cash flow from operations and existing resources are adequate to meet scheduled debt and capital lease obligations for the next 12 months. The Company maintains a $6,000,000 line of credit with $4,000,000 currently drawn.
- Capital Commitments: The Company has approximately $22,000,000 in remaining commitments to purchase equipment, including two Still River Monarch 250 systems, a new Perfexion unit, and an LGK Model 4 unit. Financing for these purchases is not yet secured.
- Investment Risk: The Company holds a $2,617,000 preferred stock investment in Still River Systems and has made $2,000,000 in deposits for unapproved proton beam therapy systems. Management notes there is no assurance of FDA approval or future financing for these assets.
- Contract Mix: As of the second quarter of 2008, the Company has no Gamma Knife net revenue sharing contracts; all are now fee-per-use or retail (turn-key) arrangements.
Investor Verification Checklist
- Contract Renewals: Verify the status of the 14 fee-per-use and 4 retail contracts, given the recent loss of three sites.
- Still River Investment: Assess the risk of the $4.6 million total exposure (equity + deposits) to Still River Systems, specifically regarding FDA approval timelines for the Monarch 250 system.
- Financing Availability: Confirm the Company's ability to secure the necessary financing for the $22 million in equipment purchase commitments.
- Procedure Volume Trends: Monitor if the decline in procedure volume (down 20% YTD) stabilizes following the recent equipment upgrades.
- Debt Service: Review the schedule of $9.75 million in debt payments and $1.3 million in capital lease payments due in the next 12 months against projected cash flows.